Opipramol

CAS: 315-72-0

Ref. 3D-FO26574

Product Information

• Name: Opipramol
• Synonyms: 4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanolN-[3-[4-(2-Hydroxyethyl)piperazino]propyl]iminostilbene, 1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-, 4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol, 5H-Dibenz(b,f)azepine, 5-(3-(4-(2-hydroxyethyl)-1-piperazinyl)propyl)-, 5H-Dibenz[b,f]azepine, 1-piperazineethanol deriv., Brn 0627076, Endison, G 33040, Gr 33040, N-(3-(4-(2-Hydroxyethyl)piperazino)propyl)iminostilbene, Nisidana, Nsc 169867, Opipramol G, Opipramol [INN:BAN], Opipramolum, Opipramolum [INN-Latin], Opramidol, Unii-D23Zxo613C

Description

Opipramol is a tricyclic antidepressant drug that is used to treat bowel disease. It has been shown to have an effect on locomotor activity, dopamine levels, and ryanodine receptor. Opipramol binds to the rat liver microsomes and inhibits mitochondrial functions by inhibiting the synthesis of ATP. It also increases fat cell size by stimulating lipogenesis in fat cells, which may lead to weight gain. This drug also modulates biological samples such as serum or plasma. Opipramol has been shown to have anti-inflammatory effects in rats with chronic colitis, reducing symptoms such as pain and diarrhea.

• Brand: Biosynth

Chemical properties

• Molecular weight: 363.5 g/mol
• Formula: C₂₃H₂₉N₃O
• Purity: Min. 95%
• Color/Form: Powder
• InChI: InChI=1S/C23H29N3O/c27-19-18-25-16-14-24(15-17-25)12-5-13-26-22-8-3-1-6-20(22)10-11-21-7-2-4-9-23(21)26/h1-4,6-11,27H,5,12-19H2
• InChI key: InChIKey=YNZFUWZUGRBMHL-UHFFFAOYSA-N
• SMILES: OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1